AbbVie
ABBV
#25
Rank
A$593.82 B
Marketcap
$336.38
Share price
-0.24%
Change (1 day)
22.85%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2023 (TTM): $5.55

According to AbbVie's latest financial reports the company's current EPS (TTM) is $5.85. In 2022 the company made an earnings per share (EPS) of $10.59 an increase over its 2021 EPS that were of $10.31.

EPS history for AbbVie from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.55-47.62%
2022$10.592.63%
2021$10.31125.21%
2020$4.58-45.69%
2019$8.4348.35%
2018$5.687.6%
2017$5.28-9.3%
2016$5.8315.48%
2015$5.04185.53%
2014$1.77-57.11%
2013$4.12-21.69%
2012$5.2655.73%
2011$3.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.96-49.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.31 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.63 47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.50 284.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.98 19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.35 401.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.57-4.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.16-46.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.12-46.75%๐Ÿ‡บ๐Ÿ‡ธ USA